🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Michael E. Zegans

Dartmouth College

ORCID: 0000-0003-3074-7589

Also affiliated with Dartmouth–Hitchcock Medical Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis”.

Cefiderocol is an effective topical monotherapy for experimental extensively-drug resistant Pseudomonas aeruginosa keratitis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.31.555778
N/A
0DataRank · unranked
0 citations

Sonya M. Mumper, Hazel Q. Shanks, Kathleen A. Yates, Jonathan B. Mandell, Michael E. Zegans +2 more

Efficacy of Cefiderocol Against Endophthalmitis Isolates

Antibiotics(2024)10.3390/antibiotics13121236
N/A
0DataRank · unranked
3 citations

Michael Hii, Hazel Q. Shanks, Eric G. Romanowski, Jonathan B. Mandell, Robert M. Q. Shanks +2 more

Combination Therapy of Cefiderocol and Polymyxin B Against Pseudomonas aeruginosa Keratitis Isolates In Vitro

Translational Vision Science & Technology(2025)10.1167/tvst.14.11.7
N/A
0DataRank · unranked
3 citations

Emily Young, Sonya M. Mumper, Kathleen A. Yates, Rachel A. F. Wozniak, Michael E. Zegans +2 more

Could a Preservative Have Prevented the Extremely-Drug Resistant Pseudomonas aeruginosa Artificial Tears Associated Eye Infection Outbreak of 2023?

Current Eye Research(2025)10.1080/02713683.2025.2553642
N/A
0DataRank · unranked
0 citations

Michael E. Zegans, Robert M. Q. Shanks, Eric G. Romanowski